Paracetamol
Paracetamol Pharmaceutical Supply Portfolio
Overview of Paracetamol
Paracetamol is one of the most widely used non-opioid analgesic and antipyretic molecules in global healthcare systems. It is included in multiple national formularies and is routinely supplied across hospital, institutional, and pharmaceutical distribution channels.
Oddway International provides paracetamol pharmaceutical supply as part of its broader analgesic medicines portfolio, supporting licensed importers, distributors, hospitals, and institutional healthcare buyers in international markets.
Our operations are strictly B2B. We do not sell medicines to individuals or operate as a retail or online pharmacy.
Paracetamol in Analgesic Drug Supply
Within the analgesic drugs category, paracetamol is valued for its broad applicability across clinical and non-clinical settings. It is manufactured and supplied in multiple pharmaceutical forms to support different routes of administration and institutional requirements.
As a molecule, paracetamol is supplied for:
- Hospital and clinical use
- Institutional healthcare programs
- Pharmaceutical wholesale and export supply
All supply is subject to regulatory feasibility and buyer licensing.
Paracetamol Formulations We Supply
Oddway International structures paracetamol supply at the molecule level, with individual formulation pages providing detailed information for institutional procurement.
Paracetamol Injection & IV Infusion
Intravenous paracetamol formulations are commonly supplied for hospital and clinical environments where oral administration is not appropriate.
Formulations include:
- Paracetamol Injection 2ml
- Ready-to-use Paracetamol IV infusion solutions
Paracetamol Tablets (Oral Solid Dosage)
Paracetamol tablets are supplied for pharmaceutical distribution and institutional procurement programs.
Common strengths include:
Pediatric Paracetamol Formulations
Liquid oral formulations are supplied for pediatric and institutional healthcare use where appropriate.
Available formats include:
Paracetamol Suppositories
Rectal dosage forms are supplied for regulated pharmaceutical markets where clinically indicated.
→ Paracetamol Suppository Supply
Manufacturing, Quality & Compliance
All paracetamol products supplied by Oddway International are sourced from manufacturers compliant with international quality standards, including:
- WHO-GMP manufacturing guidelines
- ISO-certified quality management systems
- Export-ready batch documentation
- Product traceability and quality assurance protocols
Regulatory documentation such as Certificates of Analysis (COA) and MSDS is available upon request for qualified buyers.
Export & Institutional Supply Model
Oddway International supports bulk and institutional paracetamol supply for international pharmaceutical markets, including:
- Licensed pharmaceutical distributors
- Hospitals and healthcare institutions
- Government and tender-based procurement programs
We coordinate export logistics, documentation, and regulatory alignment in accordance with destination-country import requirements.
Regulatory & Compliance Declaration
- Paracetamol is supplied strictly under a B2B pharmaceutical model
- No retail, online pharmacy, or direct-to-consumer sales
- Supply is restricted to licensed and authorized entities only
- Product availability depends on local regulatory approvals
Why Source Paracetamol Through Oddway International
- Structured paracetamol pharmaceutical supply portfolio
- Part of a regulated analgesic medicines supplier framework
- Access to WHO-GMP compliant manufacturers in India
- Experience supporting institutional and export markets
- Clear documentation and compliance-focused operations
Frequently Asked Questions
Yes. Paracetamol is supplied as a core molecule within our analgesic medicines portfolio.
Yes. Injectable, oral, pediatric, and special dosage forms are supplied subject to regulatory feasibility.
Yes. Documentation is available upon request for qualified buyers.
We support international markets across Asia, Africa, the Middle East, Latin America, and CIS regions, subject to regulatory approval.